A panel of outside advisers to the US Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.
FDA votes to oppose Pfizer COVID-19 vaccine booster for those 16+
